Vesanoid, the first vitamin A derivative that's been approved for treating cancer
Roche is now marketing Vesanoid, the first vitamin A derivative that's been approved for treating cancer.
Vesanoid is an oral form of tretinoin...the same ingredient that's in Retin-A.
Retinoids don't kill cancer cells like traditional chemo-therapy. They help get immature cancer cells to differentiate, and mature normally. These mature cells then die naturally. Vesanoid is only approved for a rare form of leukemia. But oral retinoids also show promise for lung, breast, and ovarian cancers.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote